You searched for metabolic diseases - Page 42 of 64

News and Trends 14 Dec 2022

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

…whose research at the University of Oxford focuses on the molecular mechanisms underlying neurodegenerative diseases, and Howard J Federoff, former distinguished Professor of Neurology at University of California, Irvine, and…

December 14, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

…urticaria. Capsida Biotherapeutics Gene therapy platform company Capsida Biotherapeutics is working on the development of a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening diseases…

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 25 Aug 2022

Evotec SE acquires highly-flexible drug manufacturing space for €1

…in depth – and with it the number of rare diseases that we can meaningfully distinguish and target with precision medicine. “Evotec DS reinforces our commitment to rare diseases by…

August 25, 2022 - 2 minutesmins - By Liza Laws

Interview 20 Mar 2018

Why It’s the Best Time to Be in Cell and Gene Therapy

…for diseases with short-term mortality, such as cancer. However, for more complex, chronic diseases such as diabetes, he expects “it will take a long time to get there.” With the…

March 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

genetic sequencing DNA Human Genome Project HGP

Opinion 14 Apr 2023

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

…and treatment in the fields of cancer, infectious diseases, rare and undiagnosed diseases, non-communicable diseases and pharmacogenomic diseases, all of which are important areas of research that can contribute to…

April 14, 2023 - 6 minutesmins - By External Contributor

News and Trends 9 Mar 2016

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

Boehringer Ingelheim (Germany) has entered a new collaboration with AbbVie (US) to develop two new candidates for immune diseases, including psoriasis and Crohn’s disease. Therapies for immune diseases continue to…

March 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

Navigating cell and gene therapy manufacturing with a long-term partnership

Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases, but developers face key challenges before these treatments reach patients’ bedsides. A long-term partnership with…

January 17, 2023 - 7 minutesmins - By Alexander Burik

News and Trends 15 Nov 2022

BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS

…for the treatment of neurodegenerative diseases. 3P BioPharmaceuticals’ role will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be…

November 15, 2022 - 2 minutesmins - By Jim Cornall

Interview 19 Aug 2022

How re-engineering antibodies can prevent allergies

…seeing in immunotherapies ushering in a new era of mobilizing immune cells to fight off diseases, such as cancers and autoimmune diseases, do you think it will be possible to…

August 19, 2022 - 9 minutesmins - By Omnia Ibrahim

News and Trends 20 Dec 2016

What Does ‘Anti-Aging Treatment’ Mean in Biotech?

…it harder to advance treatments to prevent the diseases of aging. However, new strategies for turning promising aging science into medicines are beginning to emerge” Following leaps and bounds in…

December 20, 2016 - 5 minutesmins - By Evelyn Warner

News and Trends 21 Jul 2022

Eiger receives European approval for progeria treatment

Eiger BioPharmaceuticals Inc., which focuses on the development of innovative therapies to treat and cure hepatitis delta virus and other serious diseases, has received marketing authorization from the European Commission…

July 21, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 29 Aug 2019

HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs

…year to fund the development of antibodies tackling autoimmune diseases. Denmark-based Genmab raised an enormous €450M ($506M) to fund antibody drugs for cancer and autoimmune diseases when it entered the…

August 29, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

Five biotech companies taking Los Angeles by storm

Evotec SE acquires highly-flexible drug manufacturing space for €1

Why It’s the Best Time to Be in Cell and Gene Therapy

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

Navigating cell and gene therapy manufacturing with a long-term partnership

BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS

How re-engineering antibodies can prevent allergies

What Does ‘Anti-Aging Treatment’ Mean in Biotech?

Eiger receives European approval for progeria treatment

HiFiBiO’s €60M Series C to Fund Cancer and Autoimmune Disease Antibody Drugs

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!